Stimulated IFNγ and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns

Artificial Organs

Volumn 24, Issue 10, 2000, Pages 767-772

  Alscher, Dominik Mark ^a   Pauli Magnus, Christiane ^a   Kuhlmann, Ulrich ^a   Mettang, Thomas ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Cytokines; Dialysis; Immunology; Lymphocytes; T cell; Transplantation

Indexed keywords

BLOOD; CYTOLOGY; DIALYSIS; PATIENT TREATMENT;

BLOOD MONONUCLEAR CELLS; CELL-BE; CELL/B.E; CELL/BE; CYTOKINES; HAEMODIALYSIS; MONONUCLEAR CELLS; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPIES; TRANSPLANTATION;

T-CELLS;

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MONONUCLEAR CELL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; CASE CONTROL STUDY; CELLULAR IMMUNITY; IMMUNOLOGY; MIDDLE AGED; MONOCYTE; NONPARAMETRIC TEST; RENAL REPLACEMENT THERAPY; SECRETION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; RENAL REPLACEMENT THERAPY; STATISTICS, NONPARAMETRIC;

EID: 0033626441     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2000.06648.x     Document Type: Article

References (27)

1. ESRD patients without comorbid risk factors at the start of hemodialysis are ideal as survival comparison population
2. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital hemodialysis: A multicentric study
3. Renal transplantation
4. Cardiac disease in chronic uremia: Clinical outcome and risk factors
5. Outcome and risk factors of ischemic heart disease in chronic uremia
6. Cell-mediated immune reactions
7. Effect of renal dialysis therapy modality on T-cell cytokine production
8. Cytokine production in patients on dialysis
9. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: Evaluation by confocal laser scanning fluorescence microscopy
10. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: Maturity, cytokine synthesis, and arachidonic acid metabolism
11. The molecular immunology of acute rejection: An overview
12. Regulation of the immune response: The TH1/TH2 concept
13. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression
14. Immunological techniques
15. In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients
16. Cells involved in the immune response
17. Cyclosporine A is associated with a shift of the Th1/Th2 balance in liver transplant patients
18. Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation
19. Immunologic function and survival in hemodialysis patients
20. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients
21. Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients
22. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients
23. Cross-sectional assessment of nutritional and immune status in renal patients undergoing continuous ambulatory peritoneal dialysis
24. Role of lymphatics in peritoneal dialysis
25. The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy
26. Altered cytokine production in the elderly
27. Dysregulation between TH1 and TH2 T-cell subpopulations in the elderly